Journal of Thoracic Oncology
Latest Publications

TOTAL DOCUMENTS

19696

(FIVE YEARS 6305)

H-INDEX

122

(FIVE YEARS 27)

Published By Elsevier

1556-0864

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.10.019 ◽

2022 ◽

Vol 17 (1) ◽

pp. 10-12

Author(s):

Hiromasa Yamamoto ◽

Yosuke Togashi

Keyword(s):

Adjuvant Chemotherapy ◽

Programmed Death Ligand 1 ◽

Premetastatic Niche ◽

Programmed Death

Download Full-text

Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.10.012 ◽

2022 ◽

Vol 17 (1) ◽

pp. 19-21

Author(s):

Philippe Joubert ◽

William D. Travis

Keyword(s):

Ground Glass Opacity ◽

Pulmonary Adenocarcinoma ◽

Ground Glass ◽

Prognostic Impact

Download Full-text

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)03371-2 ◽

2022 ◽

Vol 17 (1) ◽

pp. A7-A10

Download Full-text

Editorial Board

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)03365-7 ◽

2022 ◽

Vol 17 (1) ◽

pp. A1-A2

Download Full-text

Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.07.029 ◽

2022 ◽

Vol 17 (1) ◽

pp. 30-33

Author(s):

Paul Baas

Keyword(s):

Standard Of Care ◽

First Line

Download Full-text

Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.004 ◽

2022 ◽

Vol 17 (1) ◽

pp. 34-37

Author(s):

Dean A. Fennell ◽

Sean Dulloo

Keyword(s):

Standard Of Care ◽

First Line

Download Full-text

Continuation of Lorlatinib in ALK-positive NSCLC Beyond Progressive Disease

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.12.011 ◽

2022 ◽

Author(s):

Sai-Hong I. Ou ◽

Benjamin J. Solomon ◽

Alice T. Shaw ◽

Shirish M. Gadgeel ◽

Benjamin Besse ◽

...

Keyword(s):

Progressive Disease ◽

Alk Positive

Download Full-text

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.10.002 ◽

2022 ◽

Vol 17 (1) ◽

pp. 16-18

Author(s):

Katsuhiro Masago ◽

Shiro Fujita

Keyword(s):

Lung Cancer ◽

Cancer Treatment ◽

Lung Cancer Treatment

Download Full-text

Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.12.005 ◽

2022 ◽

Author(s):

Saverio Caini ◽

Marco Del Riccio ◽

Virginia Vettori ◽

Vieri Scotti ◽

Chiara Martinoli ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Overall Survival ◽

Cancer Patients ◽

Meta Analysis ◽

Lung Cancer Patients ◽

Quitting Smoking

Download Full-text

The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.12.014 ◽

2022 ◽

Author(s):

Jennifer L. Sauter ◽

Sanja Dacic ◽

Francoise Galateau-Salle ◽

Richard L. Attanoos ◽

Kelly J. Butnor ◽

...

Keyword(s):

World Health Organization ◽

World Health ◽

World Health Organization Classification ◽

Classification Of Tumors ◽

Health Organization

Download Full-text

Journal of Thoracic Oncology
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma

Table of Contents

Editorial Board

Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Continuation of Lorlatinib in ALK-positive NSCLC Beyond Progressive Disease

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis

The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification

Export Citation Format

Journal of Thoracic OncologyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Programmed Death-Ligand 1–Rich Premetastatic Niche in Adjuvant Chemotherapy

Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma

Table of Contents

Editorial Board

Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma

Continuation of Lorlatinib in ALK-positive NSCLC Beyond Progressive Disease

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis

The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification

Journal of Thoracic Oncology
Latest Publications